EMR
Emerson Electric Co.
ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP)
Emerson Electric (EMR) Stock: Buy, Sell, or Hold?
$167.06
-0.48 (-0.29%)
▼
5d:
-1.98%
30d:
+2.18%
90d:
+1.74%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect EMR Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (47%)
Quality Score
53/100
Position
EXTENDED
30-Day Fair Range
$160.41 – $167.00
Position: EXTENDED
Forward P/E & Valuation
23.1x
FAIR
vs 20.5x historical avg
Wall Street Target
$182.79
+9.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$160.35 / $172.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: EMR is fairly valued with market pricing in 4.0% annual growth. Fine to hold or accumulate slowly on dips.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Oct 19, 2026 at $161.62 · last confirmed Nov 9, 2026
Strength: 5.3/10
Get Alerted When EMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$210.14
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$130.48
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EMR is currently trading at $167.06, which is considered extended relative to its 30-day fair value range of $160.41 to $167.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.1) compared to its historical average (20.5). At these levels, the market is pricing in 4.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EMR is in a strong uptrend. The price is approaching resistance at $172.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EMR is in a strong uptrend. The price is approaching resistance at $172.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$160.41 -
$167.00
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
Trading Range & Key Levels
30-Day Trading Range
$160.41 -
$167.00
Current vs Trading Range
EXTENDED
Support Level
$160.35
Resistance Level
$172.00
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding EMR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($182.79)
- NEUTRAL: Market pricing in 4.0% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
23.05
Wall Street Target
$182.79
(+9.4%)
Revenue Growth (YoY)
7.1%
Earnings Growth (YoY)
18.5%
Profit Margin
14.2%
Valuation Premium vs History
+4.0% premium
PE vs Historical
23.1 vs 20.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.0%
(market-implied from PE analysis)
1-Year Target
$173.74
(+4%)
2-Year Target
$180.69
(+8%)
3-Year Target
$187.92
(+13%)
3-Yr Target (if PE normalizes)
(PE: 23→21)
PE COMPRESSION
$167.15
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 10.4%)
$224.86
(+35%)
Base:
(SPY PE: 19.9, Growth: 10.4%)
$193.77
(+16%)
Bear:
(PE: 16.9, Growth: 10.4%)
$164.70
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 34.98 | Current EPS (TTM): $4.79
Bull Case
$278.89
(+67%)
Analyst growth 51.3%, PE expands to 38.5
Base Case
$253.54
(+52%)
Market implied 51.3%, PE stable at 35.0
Bear Case
$113.93
(-32%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share EMR Analysis
Share this live EMR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EMR)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Xylem is set to report Q3 earnings on Oct. 27, with revenues and earnings expected to grow. The Water Infrastructure segment is expected to benefit from infrastructure projects in the US, while weakness in water treatment and lower demand in China may impact performance. The Measurement & Control Solutions segment could be affected by electric metering project delays, but the advanced metering solutions business is gaining popularity.
Key Retail Themes:
Expected earnings growth
Segment performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:43 AM ET
Data refreshes hourly during market hours. Next update: 3:43 AM
Data refreshes hourly during market hours. Next update: 3:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EMR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Industrial Machinery Stocks
Top-rated stocks in Specialty Industrial Machinery by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GEV
GE Vernova LLC |
STRONG BUY
38 analysts |
$1183 | 60 HOLD |
|
ETN
Eaton Corporation PLC |
STRONG BUY
28 analysts |
$477 | 57 HOLD |
|
PH
Parker-Hannifin Corporat… |
STRONG BUY
26 analysts |
$1140 | 47 HOLD |
|
CMI
Cummins Inc |
BUY
22 analysts |
$709 | 54 HOLD |
|
GNRC
Generac Holdings Inc |
STRONG BUY
22 analysts |
$289 | 49 HOLD |
Advanced EMR Option Strategies
Professional options setups generated by AI based on today's EMR price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EMR Research Pages
